妊娠期糖耐量减低的处理与新生儿结局的关系  

Treating Women with Gestational Impaired Glucose Tolerance Reduces Adverse Outcome of Pregnancy

作　　者：李萍[1] 杨慧霞[1] 董悦 

机构地区：[1]南京医科大学附属南京第一医院妇产科,210006

出　　处：《中华妇产科杂志》1999年第8期462-464,共3页Chinese Journal of Obstetrics and Gynecology

摘　　要：目的　探讨妊娠期糖耐量减低的合理处理与胎儿及新生儿预后的关系。方法　收集１９９６ 年７ 月～１９９８ 年６ 月妊娠期糖耐量减低的孕妇９８ 例，其中６１ 例在孕期接受饮食控制或胰岛素治疗（ 治疗组） ；３７ 例未进行治疗（ 未治疗组） ，对两组围产儿妊娠结局进行比较。结果　治疗组巨大儿发生率为６ ．６５ ％ 明显低于未治疗组的３５ ．１４ ％ （ Ｐ＜ ０ ．０１） ，胎儿窘迫发生率治疗组为１９ ．６７ ％ ，未治疗组为３７ ．８４ ％ ，两组比较，差异有显著性（ Ｐ＜ ０ ．０５） ，治疗组新生儿病率低于未治疗组，但差异无显著性。结论　对妊娠期糖耐量减低的孕妇合理治疗，可降低胎儿及新生儿的发病率。Objective To study the treatment of women with gestational impared glucose tolerance (GIGT) in relation to outcome of fetus and newborns. Methods 98 women with GIGT were randomized into untreated (37 mothers) and treated groups (61 mothers) that included diet control and insulin therapy. The perinatal outcomes were compared in the two groups. Results The incidence of macrosomia ( P <0.01) and fetal distress ( P <0.05) was found to be significantly higher in the untreated group when compared with the treated group. The prevalence of neonatal metabolic complications in the untreated group was higher than that of the treated group as well. Conclusion Treatment of women with GIGT will reduce adverse outcome in pregnancy.

关 键 词：妊娠合并症 糖耐量减低 新生儿 预后 GIGT 

分 类 号：R714.256[医药卫生—妇产科学] R722.07[医药卫生—临床医学]